Logo

Illumina Passes Antitrust Hurdle to Acquire Solexa

Dec 21, 2006
NEW YORK (GenomeWeb News) — Illumina today said it has received clearance under Hart-Scott-Rodino Antitrust regulations to continue with its proposed acquisition of Solexa.
 
The companies yesterday said Solexa and Illumina shareholders will vote on aspects of the acquisition on Jan. 26, 2007.

Filed under

Clinical Sequencing
Sequencing
Breaking News
The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.